FluidAI Medical, formerly known as NERv Technology Inc. and based in Kitchener, Canada, has successfully raised $15M in a Series A funding round. The financing was led by SOSV and Graphene Ventures, with participation from several esteemed investors, paving the way for the expansion of FluidAI's AI-driven postoperative patient monitoring solutions into global markets. CEO Youssef Helwa heads the company, which focuses on utilizing artificial intelligence to detect postoperative leaks early, significantly enhancing clinical outcomes through their Stream™ Platform, a groundbreaking combination of advanced sensors and cutting-edge AI algorithms.